News · 26 weeks28+100%
2025-12-282026-06-21
Mix1890d
- SEC Filings9(50%)
- Other8(44%)
- Earnings1(6%)
Latest news
25 items- SECSEC Form 6-K filed by IM Cannabis Corp.6-K - IM Cannabis Corp. (0001792030) (Filer)
- PRIM Cannabis Corp. Enters into Letter of Intent to Sell its European Activities, Expects to Significantly Reduce Debt by CAD$10.5 millionTransaction Expected to Streamline Operations, Retain Israeli Business, Improve Working Capital through debt reduction and Cash Flow While Enabling the Pursuit of New Investment Opportunities as Previously AnnouncedTORONTO and GLIL YAM, Israel, June 18, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC), a medical cannabis company with operations in Israel and Germany, is pleased to announce that it has entered into a non-binding letter of intent (the "Letter of Intent") with Slil.com Holding Ltd., a privately-held Israeli entity beneficially owned and controlled by Oren Shuster, the Company's Chief Executive Officer, a director and debtholder of IMC ("Slil"), purs
- SECSEC Form EFFECT filed by IM Cannabis Corp.EFFECT - IM Cannabis Corp. (0001792030) (Filer)
- SECSEC Form 6-K filed by IM Cannabis Corp.6-K - IM Cannabis Corp. (0001792030) (Filer)
- PRIM Cannabis Announces Form F-3 Resale Registration Statement FilingTORONTO and GLIL YAM, Israel, June 9, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC), a medical cannabis company with operations in Israel and Germany, announces that, further to its press releases dated May 7, 2026 and June 3, 2026, it has filed a resale registration statement on Form F-3 (the "Resale Registration Statement") with the Securities and Exchange Commission (the "SEC"). The Resale Registration Statement registered an aggregate of 17,276,931 common shares in the capital of the Company ("Common Shares") comprised of: (i) up to 4,000,000 Common Shares issued or issuable upon the conver
- SECSEC Form F-3 filed by IM Cannabis Corp.F-3 - IM Cannabis Corp. (0001792030) (Filer)
- SECSEC Form 6-K filed by IM Cannabis Corp.6-K - IM Cannabis Corp. (0001792030) (Filer)
- PRIM Cannabis Raises US$225,000 of Gross Proceeds in Convertible Note FinancingTORONTO and GLIL YAM, Israel, June 3, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC), a medical cannabis company with operations in Israel and Germany, today announced the closing of a US$225,000 convertible note financing in a private placement with an institutional investor (the "Lender"). Pursuant to a note purchase agreement between the Company and Lender dated June 3, 2026 (the "June Note Purchase Agreement"), the Company issued the Lender a note in the principal amount of US$225,000, with an original issuance discount of 10% (the "June Note").The June Note bears interest at a rate of 8% per annum, increasing to 14% upon the occurrence and continuation of
- SECSEC Form 6-K filed by IM Cannabis Corp.6-K - IM Cannabis Corp. (0001792030) (Filer)
- PRIM Cannabis Corp. Announces First Quarter 2026 Financial ResultsTORONTO and GLIL YAM, Israel, May 13, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC), a medical cannabis company with operations in Israel and Germany, today announced its financial results for the first quarter ended March 31, 2026. All amounts were reported in Canadian dollars, unless otherwise stated. For the three months ended March 31, 2026, the Company recorded revenues of $8.7 million, gross profit of $1.4 million, operating loss of $1.7 million, and a net loss of $2.5 million, or $0.38 per share. The Company also continued to advance its co
- SECSEC Form 6-K filed by IM Cannabis Corp.6-K - IM Cannabis Corp. (0001792030) (Filer)
- PRIM Cannabis Raised US$550,000 of Gross Proceeds in Convertible Note FinancingsTORONTO and GLIL YAM, Israel, May 7, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC), a medical cannabis company with operations in Israel and Germany, today announced the closing of a US$300,000 convertible note financing in a private placement with an institutional investor, bringing the total gross proceeds raised in recent similar financings to US$550,000. First NotePursuant to a note purchase agreement between the Company and Lender dated April 6, 2026 (the "First Note Purchase Agreement"), the Company issued the Lender a note in the principal amount of US$250,000, with an original issuance discount of 10% (the "First Note").The First Note bears interest at
- SECSEC Form 6-K filed by IM Cannabis Corp.6-K - IM Cannabis Corp. (0001792030) (Filer)
- PRIMC Announces Receipt of Nasdaq Minimum Bid Price NotificationTORONTO and GLIL YAM, Israel, April 10, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC), a medical cannabis company with operations in Israel and Germany, today announced that it has received a written notice (the "Notice") from Nasdaq Stock Market LLC ("Nasdaq") indicating that the Company is not in compliance with the minimum bid price requirement for continued listing set forth in Nasdaq Listing Rule 5550(a)(2), which requires listed securities to maintain a minimum bid price of $1.00 per share. Under Nasdaq Listing Rule 5810(c)(3)(A), the Company has been granted a period of 180 calendar days to regain compliance with the minimum bid price requirement. The N
- SECSEC Form 6-K filed by IM Cannabis Corp.6-K - IM Cannabis Corp. (0001792030) (Filer)
- SECSEC Form 6-K filed by IM Cannabis Corp.6-K - IM Cannabis Corp. (0001792030) (Filer)
- PRIM Cannabis Reports 2025 Results: Revenue of C$54.7 Million with Over 134% Growth in Germany and Positive Operating Cash FlowTORONTO and GLIL YAM, Israel, March 31, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC), a medical cannabis company with operations in Israel and Germany, today reported its audited consolidated financial results as of and for the full year ended December 31, 2025. The Company achieved a major operational milestone by generating positive cash flow from operating activities of C$4.7 million for the year ended December 31, 2025, a significant turnaround from negative cash flow in 2024, while delivering high revenue growth in Germany, completing financing transactions, and strengthening its cash position. 2025 Key Highlights (All figures in CAD thousands):Revenue t
- SECSEC Form 20-F filed by IM Cannabis Corp.20-F - IM Cannabis Corp. (0001792030) (Filer)
- SECSEC Form 6-K filed by IM Cannabis Corp.6-K - IM Cannabis Corp. (0001792030) (Filer)
- PRIMC Announces a Strategic Entry to the Cyber Drone Interception and Satellite Intelligence Markets by Signing a Non-Binding Agreement to Acquire 51% of Blackaxe TechnologiesTORONTO and GLIL YAM, Israel, March 17, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC), a medical cannabis company with operations in Israel and Germany, today announced that, following its previous announcement regarding its decision to explore the introduction of additional business activities, it has entered into a non-binding letter of intent (the "LOI") to acquire 51% of Blackaxe Technologies Spolka z Organiczona ("Blackaxe"), a Polish technology company specializing in advanced defense and intelligence solutions. The proposed transaction represents a potential strategic expansion for IMC into the defense and homeland security technology sectors.Black Axe
- SECSEC Form EFFECT filed by IM Cannabis Corp.EFFECT - IM Cannabis Corp. (0001792030) (Filer)
- SECSEC Form F-3 filed by IM Cannabis Corp.F-3 - IM Cannabis Corp. (0001792030) (Filer)
- SECSEC Form 6-K filed by IM Cannabis Corp.6-K - IM Cannabis Corp. (0001792030) (Filer)
- PRIM Cannabis Raises US$2,171,660.40 in Note Purchase AgreementsTORONTO and GLIL YAM, Israel, Jan. 26, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC), a leading medical cannabis company with operations in Israel and Germany, today announced that it has raised a total of US$2,171,660.40 in debt financings from an arm's length third party (the "Lender") in order to manage the Company's current liquidity requirements. First Note Pursuant to a note purchase agreement between the Company and Lender dated January 7, 2026 (the "First Note Purchase Agreement"), the Company issued the Lender a note in the principal amount of US$1,538,749, after application of an original issuance discount of 10% (the "First Note"). The First Note b
- SECSEC Form 6-K filed by IM Cannabis Corp.6-K - IM Cannabis Corp. (0001792030) (Filer)
IMCC FAQ
6 questionsWhat does IM Cannabis Corp. do?
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada. It offers strains under the Roma, Dairy Queen, London, Tel Aviv, Paris, and Pandora Box brands; and CBD oil products under the IMC brand. The company also offers its intellectual property related services to the medical cannabis industry. IM Cannabis Corp. is headquartered in Tel Aviv-Yafo, Israel.Where does IMCC stock trade?
IM Cannabis Corp. (IMCC) is listed on NASDAQ.What sector and industry is IMCC in?
IM Cannabis Corp. operates in the Health Care sector, Medicinal Chemicals and Botanical Products industry.What are analysts saying about IMCC?
IM Cannabis Corp. has had 3 recent analyst actions on file. The most recent action was from ROTH Capital: Buy with a $800.00 price target on 2021-10-05. Recent price targets range from $800.00 to $1050.00.What companies are similar to IMCC?
Notable peers in the same industry include PM (Philip Morris International Inc), BTI (British American Tobacco Industries p.l.c.), MO (Altria Group Inc.), RGC (Regencell Bioscience Holdings Limited), DFTX (Definium Therapeutics Inc.). Compare IMCC side-by-side with any of them on Quantisnow.How can I track IMCC on Quantisnow?
Quantisnow aggregates IM Cannabis Corp.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow IMCC to receive live email and push alerts on every new disclosure.